FEMASYS INC. - COMMON

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

12 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys to Exhibit at the Annual AAGL 2024 Global Conference

07 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

01 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

30 окт 2024 09:00:00 Источник Nasdaq GlobeNewswire

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

10 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

08 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

02 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces Infertility Clinic Customers from Coast to Coast

18 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

11 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

09 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting

05 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

03 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution

29 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

27 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update

08 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam

27 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

20 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

17 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council

16 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

09 май 2024 08:30:00 Источник Nasdaq GlobeNewswire